What’s New in Glaucoma Management?
This activity will explore updated approaches to the management of glaucoma—the “silent thief of sight” that affects an estimated 3 million Americans. It will examine the latest evidence from recent studies on minimally invasive glaucoma surgery (MIGS) procedures and discuss comparative data on more invasive surgical techniques such as trabeculectomy and tube shunt surgery. Patient cases will be introduced to enhance participants’ understanding of the glaucoma treatment process. In addition, potential future innovations in glaucoma treatment will be discussed.
This activity is provided by Optum Health Education and UnitedHealthcare Vision.
No commercial support was received for this activity.
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.
This activity is designed to meet the educational needs of optometrists who have an interest in glaucoma.
At the end of this activity, participants should be able to:
- Identify treatment approaches to glaucoma and nuances of the chronic eye disease treatment process.
- Evaluate the latest evidence on the risks and benefits of MIGS and compare these techniques to more invasive glaucoma surgical interventions.
- Describe emerging trends and potential future developments in the realm of glaucoma care.
Jeffrey L. Kegarise, OD, ABO
Diplomat, American Board of Optometry
Cool Springs Eye Care
Scott J. Fudemberg, MD, FACS
SJF Glaucoma, LLC
About the presenters
Dr. Kegarise is the president of The Center for Professional Development, Inc., a management consulting firm that assists doctors in clinical and managerial practices. He earned his doctorate of optometry at The Ohio State University and followed that with a residency in family practice optometry at The University of Alabama at Birmingham. His early career was focused on eye disease as he led optometric referral centers with Omega Health Systems in Birmingham, AL and Nashville, TN. During that time, his practices were recognized by the state of Tennessee with TN Quality Awards for business. He began his consulting career after he was recognized by the Institute for Healthcare Improvement (IHI) in Boston, MA, as one of three international experts and innovators in health care design and leadership. He served as one of the founding members of IHI’s Idealized Design in Healthcare Project (IDCOP), which created a model for ambulatory care medicine in pursuit of “ideal” care. His teaching and consultations have included lecturing to and helping leaders of large academic centers of ophthalmology, the Mayo Clinic and other health care organizations in all branches of primary care and specialty medicine. He consulted with the American Board of Internal Medicine (ABIM) to help improve methods for coordination and transition of care. He maintains faculty status with IHI and an affiliation with Dartmouth College (Hanover, NH) as an adjunct in the Dartmouth Institute Microsystem Academy.
In 2004, Dr. Kegarise left secondary care and, practicing with his wife, Susan, formally purchased Cool Springs Eye Care. The practice and its sister location in Donelson have enjoyed phenomenal growth while expanding the services, care and scope of the business. Cool Springs Eye Care was awarded the first Review of Optometric Business National Optometric Practice Innovator of the Year as well as Power Practice of the Year.
Dr. Kegarise prides himself on trying to be a better father and husband than he is an accomplished doctor of optometry and businessman. He bleeds scarlet and gray, attends as many Buckeye football games as possible and enjoys travel with his wife.
His career passion has been to combine optometry and ophthalmology together in a focus on better care for the patient. More recently, he and his wife, Susan, published One Patient at a Time: The K2 Way Playbook for Healthcare and Business Success, which seeks to improve health care and develop doctors for successful careers in clinical practice and business. He is a passionate proponent of private practice and has created, turned around and saved many eye care practices in his career. His businesses combine successful leadership, management and growth while maintaining fun and optimism in the staff and doctors.
After finishing his glaucoma fellowship at the Wills Eye Hospital in 2008, Dr. Fudemberg joined the faculty of Wills Eye and has since practiced as a specialist focused on medical and surgical care of high-risk glaucoma. He graduated magna cum laude from the University of Pennsylvania and attended medical school at St. Louis University, where he graduated with distinction in research. He served as an ophthalmology resident at the University of Kansas, where he was appointed a co-chief resident and won the Alan W. Riley Award as resident of the year.
Dr. Fudemberg has authored numerous publications in peer-reviewed journals and textbooks as well as presented work at international meetings. He was an editor of the Yearbook of Ophthalmology’s glaucoma section and has served as a reviewer for major ophthalmology journals. He is a fellow of the American College of Surgeons and College of Physicians of Philadelphia and a Diplomate of the American Board of Ophthalmology.
Elizabeth Albert, MD
Clinical Activity Manager
Optum Health Education
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Optum Health Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.
The activity faculty and planners have no financial relationships to disclose.
Method for calculating CE credit
CE credit was calculated by the complexity of content.
In support of improving patient care, this activity has been planned and implemented by Optum Health Education and UnitedHealthcare Vision. Optum Health Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Credit designation statements
Optum Health Education designates this enduring activity for a maximum of 1.0 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.
Optum Health Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization from which they wish to obtain credit.
- 1.00 AMA - Physicians
- 1.00 Attendance - General Attendance
- 1.00 COPE - Optometrists
You must be logged into your account to participate in this activity. Get started by clicking “Register/Continue” and following the instructions. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”